AnalystsPatrick R. TrucchioPatrick R. Trucchio's Stock Forecasts
AnalystsPatrick R. Trucchio
Sectors:
Industries:
Analyst Ranking
Top 3%
#149 out of 5502 analysts
Average Return
+36.46%
Win Rate
64%74 out of 116
Risk vs Reward
Poor
Good
Patrick R. Trucchio's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alto Neuroscience IncANRO | +885.34% | $3.41 | $33.60 | 2025-08-18 - 2026-08-17 | Buy |
Alto Neuroscience IncANRO | +233.09% | $11.00 | $36.64 | 2025-10-24 - 2026-09-02 | Buy |
Arrowhead Pharmaceuticals IncARWR | +222.20% | $25.68 | $82.74 | 2025-09-02 - 2026-09-01 | Buy |
Silence Therapeutics PLCSLN | +204.95% | $4.85 | $14.79 | 2025-09-16 - 2026-09-02 | Buy |
Uniqure NvQURE | +165.23% | $17.43 | $46.23 | 2025-09-08 - 2026-09-02 | Buy |
Patrick R. Trucchio Analyst Color
Get additional color on Patrick R. Trucchio's coverage of popular stocks
Patrick R. Trucchio's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | 11 | Buy | $455.00 | +70.16% | Reiterates | a day ago |
Arrowhead Pharmaceuticals IncARWR | 10 | Buy | $120.00 | +40.56% | Reiterates | 2 days ago |
Nrx Pharmaceuticals IncNRXP | 7 | Buy | $45.00 | +1,200.58% | Reiterates | 9 days ago |
Beam Therapeutics IncBEAM | 4 | Buy | $80.00 | +173.13% | Reiterates | 9 days ago |
Bright Minds Biosciences IncDRUG | 6 | Buy | $145.00 | N/A | Reiterates | 15 days ago |
Oncolytics Biotech IncONCY | 3 | Buy | $5.00 | +468.18% | Maintains | 15 days ago |
Assembly Biosciences IncASMB | 5 | Buy | $50.00 | +36.17% | Reiterates | 16 days ago |
Alto Neuroscience IncANRO | 5 | Buy | $55.00 | +50.11% | Maintains | 17 days ago |
Faeth Therapeutics IncFTH | 2 | Buy | $60.00 | +53.37% | Reiterates | 23 days ago |
Voyager Therapeutics IncVYGR | 4 | Buy | $25.00 | +606.21% | Reiterates | 24 days ago |
Compass Pathways PLCCMPS | 4 | Buy | $65.00 | +391.31% | Maintains | a month ago |
Precision Biosciences IncDTIL | 3 | Buy | $60.00 | +705.37% | Reiterates | a month ago |
Gossamer Bio IncGOSS | 5 | Buy | $2.00 | +1,056.07% | Reiterates | a month ago |
Ataibeckley IncATAI | 5 | Hold | $7.50 | +2.04% | Downgrades | a month ago |
Harmony Biosciences Holdings IncHRMY | 4 | Buy | $55.00 | +28.32% | Reiterates | 2 months ago |
Cybin IncHELP | 3 | Buy | $70.00 | +485.77% | Maintains | 2 months ago |
Uniqure NvQURE | 9 | Buy | $80.00 | +73.05% | Maintains | 2 months ago |
Agomab Therapeutics NvAGMB | 1 | Buy | $35.00 | +156.22% | Initiates Coverage On | 2 months ago |
Silence Therapeutics PLCSLN | 3 | Buy | $75.00 | +407.10% | Reiterates | 3 months ago |
Invivyd IncIVVD | 4 | Buy | $10.00 | +1,143.78% | Reiterates | 3 months ago |
Gh Research PLCGHRS | 3 | Buy | $65.00 | +131.56% | Maintains | 3 months ago |
Altimmune IncALT | 4 | Buy | $20.00 | +509.76% | Maintains | 4 months ago |
Immunocore Holdings PLCIMCR | 4 | Buy | $100.00 | +167.59% | Reiterates | 4 months ago |
Aligos Therapeutics IncALGS | 3 | Buy | $50.00 | +705.15% | Reiterates | 6 months ago |
Vir Biotechnology IncVIR | 3 | Buy | $20.00 | +73.91% | Maintains | 6 months ago |
Pharvaris NvPHVS | 4 | Buy | $60.00 | +70.60% | Reiterates | 6 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $70.00 | +79.95% | Maintains | 6 months ago |
Sangamo Therapeutics IncSGMO | 2 | Buy | $10.00 | +8,595.65% | Reiterates | 7 months ago |
Marker Therapeutics IncMRKR | 1 | Buy | $10.00 | +700.00% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.